You are here:

Pharmaceutical and other industry supporters

With the interests of people with MS at our core, we believe it is important to work cooperatively with all stakeholders in MS, including the pharmaceutical, medical equipment and biotechnology companies and contract research organisations.

Funding from industry supporters goes towards our work with health professionals. We will not accept industry funding for our publications for people affected by MS.

We will always ensure the integrity and independence of the MS Trust is maintained. All industry funding will be acknowledged on our website.

Read our full policy on working with industry supporters (pdf 110KB)

Our industry supporters

 

2017 £

 

Biogen Idec Ltd

100,000

Funding for the MS Trust's Specialist Nurse Programme

Biogen Idec Ltd

25,000

Platinum sponsorship at MS Trust Annual Conference (Nov 2017)

Biogen Idec Ltd

800

Honorarium

Biogen Idec Ltd

180

Honorarium

Genzyme, a Sanofi Company

75,000

Patient organisation support grant for Specialist Nurse Programme

Genzyme, a Sanofi Company

25,000

Platinum sponsorship at MS Trust Annual Conference (Nov 2017)

Genzyme, a Sanofi Company

1,000

Honorarium

Genzyme, a Sanofi Company

312.50

Honorarium

Merck Serono Ltd

5,000

Grant towards the Therapists Education Fund

Merck Serono Ltd

14,640

Funding for the MS Trust's Specialist Nurse Programme

Merck Serono

25,000

Platinum sponsorship at MS Trust Annual Conference (Nov 2017)

Merck Serono

1,190

Honorarium

Merck Serono

1,800

Honorarium

Novartis Pharmaceuticals (UK) Ltd

5,000

Grant towards the Therapists Education Fund

Novartis Pharmaceuticals (UK) Ltd

25,000

Platinum sponsorship at MS Trust Annual Conference (Nov 2017)

Novartis Pharmaceuticals (UK) Ltd

787.50

Honorarium

MedDay Pharmaceuticals

1,200

Honorarium

Roche

5,000

Grant towards the Therapists Education Fund

Teva UK Ltd

5,000

Grant towards the Therapists Education Fund

Print this page